Open access peer-reviewed chapter

Ocular Hypertension in Blacks

By Daniel Laroche and Kara Rickford

Submitted: December 15th 2020Reviewed: February 12th 2021Published: March 2nd 2021

DOI: 10.5772/intechopen.96606

Downloaded: 100

Abstract

Ocular hypertension occurs when intraocular pressure (IOP) is greater than the normal range with no evidence of vision loss or damage to the optic nerve. Individuals with ocular hypertension have an increased risk for glaucoma. The mean normal IOP is 15 mmHg and the mean IOP of untreated glaucoma is 18 mmHg. Elevated IOP commonly occurs in patients over the age of 50 and is often due to enlargement of the lens, narrowing of the angle, iridolenticular apposition, and pigment liberation that obstructs the trabecular meshwork. Cataract surgery and lensectomy can lower IOP and reduce the risk of glaucoma. The global wealth inequality of Blacks has created health inequities that have led to decreased access to surgical care contributing to higher rates of blindness from glaucoma. Greater education on the benefits of early cataract surgery and trabecular bypass for higher risk patients, as well as addressing wealth and health inequities, can help to bend the curve of blindness from glaucoma.

Keywords

  • ocular hypertension
  • glaucoma
  • Blacks
  • cataract surgery
  • trabecular bypass
  • African-American

1. Introduction

Ocular hypertension occurs when the pressure in the eye (intraocular pressure or IOP) is beyond the normal value with no signs of vision loss or damage to the optic nerve [1]. With ocular hypertension, the aqueous humor (fluid produced by the eye) is poorly drained. The buildup of fluid in the eye leads to an increase in IOP that could potentially lead to damage of the optic nerve, causing glaucoma [2]. The mean normal IOP is 15 mmHg and the mean IOP of untreated glaucoma is 18 mm Hg [1]. Ocular hypertension typically presents with no signs or symptoms, making it difficult to detect without access to an eye exam. Individuals with elevated IOP may be treated with cataract surgery and lensectomy [2, 3]. To properly address populations at risk for ocular hypertension, it is advantageous to determine how demographic variables may impact an individual’s susceptibility to blindness. Demographic variables are innate or non-changeable determinants of a disease. Addressing inequities in wealth, health, and access to medical care, as well as improved education on the benefits of early surgical intervention, can bend the curve of blindness from glaucoma. In this chapter, we use epidemiologic studies focusing specifically on Blacks to describe the prevalence and management of ocular hypertension.

Advertisement

2. Prevalence of ocular hypertension in blacks

In 2019, Black Americans made up 12.8% of US population, accounting for over 42 million people [4]. Although Blacks make up a minority of the population, many eye diseases, including ocular hypertension and glaucoma, affect a disproportionate number of Blacks, leading to higher rates of vision loss than documented in white-Americans [5]. Definitions of race and ethnicity have been ill-defined in past medical literature, with many overlaps. Therefore, the term “Blacks” in this context refers to an individual of black African descent. The population of Blacks in the Caribbean is over 21 million and in Africa is close to one billion [6]. There are also issues of decreased access to surgery in both locations [7].

While it has been universally accepted and documented that Blacks have higher prevalence of ocular hypertension, the degree of prevalence may differ for varying black populations. For example, the black-American and black-Caribbean populations studied in the Baltimore Eye Survey and the Barbados Eye Study, respectively, are ethnically unique. Both populations of Blacks presented with a high prevalence of ocular hypertension, but to a different degree. The prevalence of ocular hypertension in the black-Caribbean population was reported at levels nearly twice that of the black-American population [8, 9, 10, 11]. Studies have also reported a notably higher prevalence of ocular hypertension in Blacks in comparison to other racial groups (primarily white) [12, 13].

In response to a lack of substantial ocular research with Black study participants, extensive population-based studies including the Baltimore Eye Survey [9], The Ocular Hypertension Treatment Study [2], The Barbados Eye Study [8], and the African American Eye Disease Study [13] were created to address the disproportionate prevalence of eye diseases present in Blacks. Further studies are needed to continue to build upon this body of research, particularly to look at earlier interventions of cataract surgery and trabecular bypass as an earlier intervention to prevent glaucoma.

Advertisement

3. Mechanism of ocular hypertension in blacks

Studies have shown that with age the crystalline lens increases in width. During accommodation, the iris bows posteriorly. With age there is increased contact between the posterior iris pigment epithelium and lens zonules leading to pigment liberation and obstruction of the trabecular meshwork [14]. This is often seen with heavier pigment in the trabecular meshwork inferiorly compared to superiorly on gonioscopy [15]. The increased width of the lens can also lead to pupillary block and iris obstruction of the trabecular meshwork leading to elevated intraocular pressure. This common mechanism of ocular hypertension in persons over the age of 50 is often overlooked by physicians. Current physicians and those in training must be better educated to look for this clinically and intervene promptly. Early cataract surgery and lensectomy is beneficial to remove the large lens and trabecular bypass to restore aqueous outflow via the obstructed trabecular meshwork [14].

Advertisement

4. Genetic influence on ocular hypertension

Previous studies have shown intraocular pressure (IOP) to be highly heritable, indicating possible genetic influence on the development of ocular hypertension [12, 16]. There is additional substantial evidence suggesting that ocular hypertension leading to glaucoma may have a genetic component [17], but the specific genetic risk factors have not yet been identified. A 2012 genome wide association study conducted in 11,972 participants from The Netherlands, UK, Australia, and Canada investigated candidate genes in human ocular tissue to identify susceptibility to elevated IOP and glaucoma [12]. Elevated IOP commonly occurs in patients over the age of 50 and often presents with enlargement of the lens, narrowing of the angle, iridolenticular apposition, or pigment liberation that obstructs the trabecular meshwork. Genes regulating these ocular components were studied and the results revealed that genetic variants expressed in genes GAS7 and TMCO1 were associated with changes in IOP in the populations studied. Both revealed only marginal evidence for ocular hypertension, as GAS7 was associated with a 0.19 mmHg decrease in IOP and TMCO1 was associated with a 0.28 mmHg increase in IOP [12]. Additional findings revealed that individuals of European ancestry expressed the GAS7 variant at 0.44 frequency while those of African ancestry expressed the same variant at 0.12 frequency [12]. The lower frequency of this variant in Blacks may reflect the elevated IOP common in individuals of African descent and requires further research.

While impressive strives have been made over the past two decades to identify genetic components of ocular diseases [18], a comprehensive understanding of the pathophysiology has frequently been limited to individuals of European and Asian ancestry, requiring an increased need for genetic research in Blacks and other understudied populations. For example, multiple genetic variants in genes associated with elevated IOP were discovered in non-Black populations and a majority do not replicate, nor have an effect, in Blacks [19, 20, 21]. In response to an increased need for the identification of genetic risk factors that underlie elevated IOP in the understudied population of Blacks, the Primary Open-Angle African American Glaucoma Genetics (POAAGG) study was created in 2014 and took place over the course of five years to address these research disparities [22]. This study identified a genetic variation known as a single nucleotide polymorphism (SNP) involved in the homeostasis of the trabecular meshwork [23]. The trabecular meshwork (TM) is located in the anterior portion of the eye and regulates the outflow of the aqueous humor into circulation [24]. If resistance increases in the TM during aqueous humor outflow, intraocular pressure may rise leading to ocular hypertension. By identifying a genetic variant that may affect the TM in Blacks, the POAAGG study has made a pertinent finding to our understanding of the role of genetics in ocular hypertension and glaucoma. As one of the first large cohort studies with over 5,000 study participants, additional analyses are needed to further validate the implications of this study.

In addition, the progression of elevated IOP in Blacks leading to ocular hypertension is likely a combination of genetic, environmental, aging and socioeconomic factors, as well as others not mentioned. These demographic variables will continue to be explored throughout this chapter.

4.1 Central corneal thickness in ocular hypertension

Intraocular pressure is routinely measured in clinical practice to assess various conditions within the eye, including that of the optic nerve and visual field [25]. Goldmann applanation tonometry is the most common technique used to measure IOP, but its accuracy and use as a diagnostic tool may be impeded by the rigidity of the cornea [25]. A thicker cornea may cause an overestimate of IOP and a thinner cornea may cause an underestimate of IOP. The consensus on the necessity to correct IOP based on central corneal thickness is not yet clear. While CCT is statistically significant as a predictor of glaucoma development [2], it does not present as an independent risk factor [26].

The Ocular Hypertension Treatment Study (OHTS) and the European Glaucoma Prevention Study (EGPS) recognized central corneal thickness as one of the most significant predictors for primary open-angle glaucoma [2, 27]. The mean central corneal thickness is about 560 μ m and the risk for developing ocular hypertension has been reported to nearly double (hazard ratio of 1.82) for every 40 μm decrease [28]. Patients with thin corneas (<555 μm) [2] may present with an underestimated IOP reading, placing the individual at potential risk if actual IOP is elevated. The primary diagnostic criteria for ocular hypertension is IOP, so any factor that hinders this measurement may lead to an errant diagnosis. Patients with ocular hypertension typically present with thicker corneas, which may lead to an overestimation of IOP, while primary open angle glaucoma patients present with thinner corneas [29]. While the influence of elevated IOP on central corneal thickness has not yet been determined, individuals whose IOPs have been reduced pharmacologically by at least 20% demonstrated no change in corneal thickness [30].

Differences in central corneal thickness were noted between black Americans and white Americans. In the OHTS, Blacks were found to have thinner central corneal thickness (555.7 μm), resulting in lower applanation readings and a miscalculated estimation of the true level of IOP [30]. The South African Eye Study [31] also measured differences in central corneal thickness and compared the findings to measurements of intraocular pressure in Blacks, mixed ethnicity peoples, and whites. The findings revealed that Blacks had the thinnest corneas and highest IOP, followed by mixed ethnicity then white individuals.

These results suggest the possible need for refining the risk factor definitions when measuring central corneal thickness and IOP in varying populations. While obtaining a central corneal thickness measurements for all patients may not be necessary, patients with ocular hypertension should continue to be monitored to measure accurate IOP and determine possible susceptibility to glaucoma.

4.2 Morphological changes in the retinal nerve fiber layer in ocular hypertension

Differing from glaucoma, ocular hypertension presents with a normal optic nerve and no signs of damage. Ocular hypertension is often a precursor to glaucoma as abnormally high pressures in the eye may lead to damage of the optic nerve causing vision loss or blindness [1]. Studies have indicated differences in the structure of the optic nerve between Blacks and whites [32, 33]. The optic disc area was 12% larger in Blacks compared to Whites [32]. The larger optic nerve may cause a greater strain at similar pressure levels, but it is not clear if larger optic discs affect one’s susceptibility to ocular hypertension as there are incongruous reports [10, 34]. The impact of these differences has been postulated to affect the increased susceptibility of Blacks to ocular hypertension and glaucoma.

The retinal nerve fiber layer (RNFL) is primarily comprised of retinal ganglion cell axons that progressively diminish in glaucoma. As a result, the RNFL thins considerably and may present as an early manifestation of glaucoma [35]. As a precursor to glaucoma, RNFL was measured in patients with ocular hypertension and the results revealed a significant thinning of RNFL of about 15% in ocular hypertensive eyes as compared to normal eyes [36]. Other studies have yet to demonstrate significant differences RNFL between normal eyes and those with ocular hypertension, possibly due to the sensitivity of the instruments used to measure and the study population [36, 37].

Advertisement

5. Inequities contributing to ocular hypertension in blacks

Vision loss is a pertinent public health challenge that requires the efforts of many to overcome [38, 39]. Addressing these disparities involves contending with the pervasive economic and racial inequalities that have had a disproportionate impact on Blacks, particularly in healthcare utilization. These inequities are evident in a 2020 study documenting the recency of eye examinations among black adults over the age of 55 [40]. In this study, 13.4% of participants (n = 740) reported having no eye examination in the last five years and nearly 25% had not had an eye exam in the last year [40]. Concerningly, 20% of study participants with diabetes mellitus were not instructed by other healthcare providers to seek annual eye examinations.

5.1 Health and wealth inequities in blacks

Systemic and social inequities have resulted in poor health outcomes in Blacks [41]. When examining wealth in the United States, there is countless evidence of extensive racial disparities. In 2016, the net worth of the average white family in the US was nearly ten times more than that of a Black family at $171,000 and $17,150 respectively [42]. These extensive differences in wealth and income reflect the consequences of years of discrimination, segregation, and inequality that mark the history of the US from its inception. The wealth gap between Blacks and whites in the US demonstrates the differences in opportunity afforded to citizens [42]. Colonialism has contributed to similar wealth disparities in the Caribbean and Africa. Differing from the circumstances in developing countries, the eye health care system in the United States is highly capable of delivering the care necessary to treat patients [41, 43]. However, much improvement is needed in the means by which education is delivered to the public and effective screening may take place.

The history of medicine and health care in the United States is tainted by a myriad of forms of injustice and violence towards Blacks that includes segregation of medical facilities, unequal healthcare access, and disdainful medical experimentation [44, 45]. Today, these inequalities are especially evident in employment, housing, and wealth opportunities in medically underserved areas and populations (MUA/P) [46, 47, 48]. MUA/P have been defined by the Health Resources and Services Administration as areas or populations having too few health care providers, high poverty or high elderly populations [49]. In addition, there are also social factors that have had strong implications on the health outcomes of Blacks, particularly poverty, food insecurity, and affordable housing. Low-socioeconomic status and race have been independently associated with increased vision loss placing poor Blacks at an increased risk [47]. These social factors that have often led to poor health outcomes in Blacks are rooted in racism and implicit biases that have to be recognized and changed at the personal, medical, and institutional level in order to lead to change [50].

Many studies have reported the association between visual impairment and poor quality of life, as well as physical and mental illness [51, 52, 53]. Unilateral and bilateral vision loss and blindness can impact a person’s quality of life by affecting their ability to read, walk, commute, and carry out daily activities [54]. In addition to the disparities previously mentioned, blindness can exasperate the inequities faced by Blacks in the US. Early treatment of ocular hypertension by reducing elevated IOP by 20% can reduce the risk of developing glaucoma in half [2], thereby reducing the risk of blindness. Earlier cataract surgery, clear lensectomy, and trabecular bypass may reduce it even more. Implementing measures to address ocular hypertension in Blacks can help reduce the risk of blindness and address health inequities in the medical community. In addition, public policy is needed to develop models of healthcare that make services more accessible, particularly in communities that are medically underserved.

5.2 Insurance and access to care

Access to health care can impact one’s health outcomes. The utilization of healthcare may be determined by whether people know care is needed, whether obtaining care is wanted, and whether care can be accessed [55]. Access is often used to describe the ease of obtaining care, including its availability, the accommodations provided, and affordability. Health care in the United States often cannot be utilized without insurance, regardless of the presence of a healthcare provider that is geographically accessible. The public health challenge regarding ocular hypertension is that if the elevated IOP was detected earlier on, further exasperation of the condition could be slowed and potential diseases could be prevented [56, 57]. With newer surgical approaches progression can be halted with earlier cataract surgery/clear lensectomy and trabecular bypass.

Successful treatments for elevated IOP have included topical medications, surgery, or laser [58]. Reducing IOP significantly may lead to a delay in progression to optic nerve damage, visual field loss, or glaucoma [59]. Several studies have reported the impact of lack of medical care on health outcomes [60, 61]. The Salisbury Eye Evaluation Study [62] was a population-based study that sought to investigate the causes of blindness and visual impairments of adults between the ages of 65 and 84. The study revealed higher levels of blindness and visual impairments in Blacks compared to whites, with 37% of the conditions classified as surgically treatable and 44% categorized as targets for low vision remediation. The study was not able to identify patients whose eye condition was amenable and chose not to undergo surgery for reasons including financial barriers, fear of the surgical procedure, or absence of functional loss. It is important to encourage all patients, particularly those with ocular hypertension, to seek continuous to monitor their condition.

The Affordable Care Act (ACA) was enacted in March 2010 with its primary goals being to make affordable health insurance available to more people and to generally lower the cost of health care [63]. Better health outcomes in Blacks have been linked to increases in health insurance coverage under the ACA [64]. While uninsured rates were reduced, Black Americans remained 1.5 times more likely to be uninsured than non-Hispanic white Americans [65]. Additionally, data gained from the National Health Interview Survey conducted between 2014–2016 revealed that access and utilization of eye care is lower among racial and ethnic minorities [66]. Increased access to health care and affordable insurance may improve the health outcomes of vulnerable populations with ocular hypertension.

Advertisement

6. Patient education for ocular hypertension

Patient education is an interactive process in which learning may take place between the healthcare provider and the patient. Increased patient education of vision health may lead to an increasing trend of eye doctor visits. Previous studies have reported that those with more education are more likely to seek care from an eye care professional as opposed to those with less education [67]. As a result of ocular hypertension, many Black patients were reported to present to an ophthalmologist with more extensive damage to the optic nerve as compared to whites [68]. As a result, the disease progression in Blacks was more vulnerable to malignancy even after intervention is initiated. Safer earlier cataract surgery and trabecular bypass are important treatment options that should be offered earlier.

Educating patients on ocular hypertension involves sharing the risk factors associated with the eye condition such as family history, age, medical conditions, and past eye injuries, as well prevention and treatment options. Due to the asymptomatic presentation of ocular hypertension with no signs of vision loss, it is possible that patients have not/will not seek treatment until further damage and vision loss occur. Prior recorded interactions between physicians and patients have found that providers were less likely to educate Black patients about glaucoma and were also less likely to educate patients of lower health literacy about glaucoma medications [69]. It is important for the patient’s eye health that ocular hypertension and its potential progression to glaucoma are described and apprehensible, particularly to those in populations most at risk. Through patient education of ocular hypertension, the patient may better understand their susceptibility to eye disease and can seek early treatment if necessary.

Advertisement

7. Prevention and implementation of changes to address ocular hypertension in blacks

Given the information presented in this chapter, initiation of treatment for ocular hypertension may be started earlier in Blacks with the possibility of arresting or reducing elevated IOP. The aging population of adults aged 65 and older is continuously increasing with expectation of this number to reach nearly 90 million in the US by 2050 [70]. In addition, growing levels of obesity increasing the prevalence of diabetes make an increasing number of individuals at risk for vision loss in the future. As the risk factors for ocular hypertension increase, recognition of patient vulnerabilities and systemic level changes are needed to ensure that the needs of patients are properly and conveniently addressed.

Advertisement

8. Conclusion

This chapter has demonstrated the unique demographic and ocular characteristics that have affected Blacks in the progression of ocular hypertension. The combination of race, socioeconomic status, and access to treatment may influence the diagnosis and health outcome of individuals with ocular hypertension. Acknowledging these factors and implementing changes to promote early diagnosis and treatment, as well as addressing health and wealth disparities in high-risk populations, can lead to lower rates of glaucoma and blindness. Physician advice through patient education, as well as affordability, continuity, and frequent access to care has demonstrated a strong association with increased eye care services [71]. Diagnosis and early intervention of elevated levels of intraocular pressure and ocular hypertension may reduce the risk of glaucoma, vision loss, and blindness in future patients.

Advertisement

Conflict of interest

The authors declare no conflict of interest.

© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Daniel Laroche and Kara Rickford (March 2nd 2021). Ocular Hypertension in Blacks, Ocular Hypertension - The Knowns and Unknowns, Michele Lanza, IntechOpen, DOI: 10.5772/intechopen.96606. Available from:

chapter statistics

100total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Retinal Vascular Implications of Ocular Hypertension

By Fidan Jmor and John C. Chen

Related Book

A Practical Guide to Clinical Application of OCT in Ophthalmology

Edited by Michele Lanza

First chapter

Corneal Microlayer Optical Tomography Review

By Vatookarn Roongpoovapatr, Jane C. Cook, Taher K. Eleiwa, Sonia H. Yoo and Mohamed Abou Shousha

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us